NVIDIA Corp. buy BiotechBee
Start price
24.06.23
/
80%
€388.00
Target price
31.12.27
€1,000.00
Performance (%)
10.31%
End price
02.12.23
€428.00
Summary
This prediction ended on 02.12.23 with a price of €428.00. The BUY prediction by BiotechBee finished with a performance of 10.31%. A total of €0.037 was paid as dividends for this prediction. BiotechBee has 80% into this predictionNVIDIA (NVDA) is a technology company specializing in graphics processing units (GPUs), system on a chip (SoC) units, and artificial intelligence (AI) computing. Founded in 1993, the company initially started as a PC graphics company but has since expanded to dominate the gaming and professional graphics markets. NVIDIA's GPUs have become the go-to choice for gamers, and its SoCs and AI computing solutions are used in industries such as robotics, self-driving cars, and high-performance computing. The company boasts a market capitalization of over $500 billion and has consistently delivered strong financial results in recent years.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| NVIDIA Corp. | 5.907% | 5.907% |
| iShares Core DAX® | 0.597% | 3.083% |
| iShares Nasdaq 100 | 0.899% | 5.338% |
| iShares Nikkei 225® | 1.775% | -1.206% |
| iShares S&P 500 | 0.990% | 3.500% |
According to BiotechBee what are the pros and cons of NVIDIA Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread NVIDIA Corp. diskutieren
Buy mit Kursziel 1.000,0